Has Anthony Knell, PA received payments from drug or device companies?

Yes. Drug and device makers reported $4,404 in general payments to Anthony Knell, PA across 236 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anthony Knell, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anthony Knell, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anthony Knell, PA

Medical · South Charleston, WVNPI 1972609550

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.8% of the total across 236 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,643, more than ten times the $89 reported in 2021.

$4,404in general payments, 2019–2025

Across 236 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$678
Dermavant Sciences, Inc.$541
Lilly USA, LLC$448
Galderma Laboratories, L.p.$383
Regeneron Healthcare Solutions, Inc.$378
Johnson & Johnson$377
plus $2K from 14 others

What the payments were for

Food & beverage$4,26297%
Education$1423%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	48	$678
Dermavant Sciences, Inc.	28	$541
Lilly USA, LLC	27	$448
Galderma Laboratories, L.p.	22	$383
Regeneron Healthcare Solutions, Inc.	16	$378
Johnson & Johnson	22	$377
Amgen	18	$249
Verrica Pharmaceuticals Inc.	1	$195
Novartis	11	$183
Arcutis Biotherapeutics, Inc.	3	$162
Sun Pharmaceutical Industries Inc.	7	$133
Sanofi	4	$130
UCB, Inc.	6	$123
Incyte Corporation	5	$116
E.r. Squibb & Sons, L.L.C.	6	$115
Organon	2	$53
LEO Pharma Inc.	2	$52
Pfizer	2	$43
Boehringer Ingelheim	2	$33
Biofrontera Inc.	4	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

YCANTH$195
ZORYVE$127
AKLIEF$118
ORACEA$118
EPSOLAY$118
VTAMA$117

How this compares

$4,404 in reported general payments places this provider in the 85th percentile of 233 medical providers in West Virginia.

See all medical providers in West Virginia →

Medicare billing

Part B allowed, 2024

$233,111

Medicare patients

871

Services billed

3,873

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	274	$9,820
Fluorouracil	83	$4,751
Doxycycline Hyclate	191	$3,312
Ketoconazole	205	$2,955
Metronidazole	44	$2,880
Triamcinolone Acetonide	198	$2,269
Tacrolimus	22	$1,629
Betamethasone Dipropionate	29	$1,055
Mupirocin	123	$942
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet	22	$632
Nystatin	30	$522
ValacyclovirValacyclovir Hcl	28	$431
Cephalexin	19	$382
Clindamycin Phosphate	14	$382
Minoxidil	30	$329

Paid to pharmacies, not to this prescriber.

Other medical in South Charleston

Katherine BoggsSouth Charleston$46K
Katie CarpenterSouth Charleston$26K
Kellie HanselSouth Charleston$12K
Holli CaragSouth Charleston$7K
Lauren ShafferSouth Charleston$6K
Timothy DouglasSouth Charleston$6K
Jacqueline McCartySouth Charleston$5K
Kelsey MathisSouth Charleston$3K
Shelley GaumSouth Charleston$2K
Lowell LarewMorgantown$31K

See the full list for West Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →